|
| |
| | United States Patent Application: 0040247603 |
 | | Consequently, interfering with sphingolipid production and/or action may be beneficial in mitigating stroke, particularly in stroke casued by peripherical vascular disease, atherosclerosis and cardiac disorders. |  | | [0061] Applicants believe, without wishing to be bound by any particular theory, that the level of undesirable sphingolipids such as CER, SPH or S-1-P, and/or one or more of their metabolites, may be directly responsible for cardiac dysfunction, during or immediately after cardiac ischemia such as during reperfusion injury. |
|
http://appft1.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=/netahtml/PTO/search-adv.html&r=1&f=G&l=50&d=PG01&p=1&S1=20010041688&OS=20010041688&RS=20010041688
|
|
| |
| | Sphingolipid Perturbations as Mechanisms for Fumonisin Carcinogenesis |
 | | Inhibition of sphingolipid biosynthesis in rat primary hepatocyte cultures by fumonisin B |  | | Methods for the diet formulation, fumonisin analysis, and sphingolipid analysis are given in Meredith et al. |  | | This balance is maintained by the relative activity of various key enzymes in the de novo and sphingolipid turnover pathways (Figure 3A). |
|
http://ehp.niehs.nih.gov/members/2001/suppl-2/301-308riley/riley-full.html
|
|
| |
| | 2002 GRC on Glycolipid & Sphingolipid Biology |
 | | Structure activity relationships of psychosine and other lyso(glyco)sphingolipid ligands |  | | Sigma-2 receptors, sphingolipid signaling, and a novel pathway to apoptosis |  | | Sphingolipids in controlling cell growth and apoptosis with implications for the etiology, prevention and treatment of disease |
|
http://www.grc.uri.edu/programs/2002/glycolip.htm
|
|
| |
| | Enhanced Serine Palmitoyltransferase Expression in Proliferating Fibroblasts, Transformed Cell Lines, and Human Tumors ... |
 | | of flux through the sphingolipid biosynthetic pathway occurring |  | | Nagiec MM, Lester RL, Dickson RC (1996) Sphingolipid synthesis: identification and characterization of mammalian cDNAs encoding the Lcb2 subunit of serine palmitoyltransferase. |  | | Senchenkov A, Han TY, Wang H, Frankel AE, Kottke TJ, Kaufmann SH, Cabot MC (2001) Enhanced ceramide generation and induction of apoptosis in human leukemia cells exposed to DT388-granulocyte-macrophage colony-stimulating factor (GM-CSF), a truncated diphtheria toxin fused to human GM-CSF. |
|
http://www.jhc.org/cgi/content/full/51/6/715
|
|
| |
| | NSF Grant For Sphingolipid Research |
 | | Sphingolipids, lipid compounds present in all organisms except bacteria, are known to function as structural components in cells and as regulators of various biological processes. |  | | Little is known, however, about their role in plant growth and development. |  | | Lynch's research explores how and where in the cell sphingolipids are produced, transported, and degraded. |
|
http://www.eurekalert.org/pub_releases/1997-11/WC-NGFS-061197.php
|
|
| |
| | 2004 GRC on Glycolipid & Sphingolipid Biology |
 | | "Sphingolipid synthesis mediates stress induced regulation of translation" |  | | "Sphingolipidomics: New LC-MS/MS methods to elucidate sphingolipid structure, metabolism, and cellular signaling" |  | | "Overview, Sphingolipid metabolism and trafficking: A foundation for function" |
|
http://www.grc.uri.edu/programs/2004/glycolip.htm
|
|
| |
| | The World's Healthiest Foods: Feeling Great |
 | | A substance found in soybeans may reduce colon cancer risk, suggests animal research conducted by Alfred Merrill at Emory University and the Karmanos Cancer Institute. |  | | While other plants also contain sphingolipids, soy contains relatively high amounts of glucosylceramide, which researchers think may be one reason for the cancer-preventive effects of eating soy foods. |  | | The cancer-protective substance is a sphingolipid (a type of lipid or fat that, in the body, is primarily used as a constituent of nerve tissue) called soy glucosylceramide. |
|
http://www.whfoods.com/genpage.php?tname=foodspice&dbid=79
|
|
| |
| | Sphingolipid activator proteins: proteins with complex functions in lipid degradation and skin biogenesis -- Schuette ... |
 | | Using fibroblasts from these patients in cell culture feeding |  | | Burkhardt, J.K., Huttler, S., Klein, A., Mobius, W., Habermann, A., Griffiths, G., and Sandhoff, K. (1997) Accumulation of sphingolipids in SAP-precursor (prosaposin)-deficient fibroblasts occurs as intralysosomal membrane structures and can be completely reversed by treatment with human SAP-precursor. |  | | Sphingolipid activator proteins: proteins with complex functions in lipid degradation and skin biogenesis -- Schuette et al. |
|
http://glycob.oxfordjournals.org/cgi/content/full/11/6/81R
|
|
| |
| | Aloe: Aloe Serum #1: Glycoceramides Sphingolipid Complex |
 | | Rich in Glycoceramides and Sphingolipid Complex, enhances with Cyclomethicone. |  | | These fresh individual dose Serum Caps assist in renewing your skin's barrier function and essential moisture binding capacity. |
|
http://www.julietsdayspa.com/products/aloe/prod_details.php?prod=D006
|
|
| |
| | Murata Lab.Kyoto University |
 | | They are characteristic in their abilities to degrade a wide variety of refractory environmental pollutants, and to carry out a variety of other biotechnologically useful processes, such as the biosynthesis of valuable biopolymers. |  | | Sphingomonads are widely distributed in nature, and contain a suite of 'signature' sphingolipid components. |  | | This signature totally replaces the lipopolysaccharide (LPS) structure characteristic of conventional Gram-negative bacteria. |
|
http://www.molbiotech.kais.kyoto-u.ac.jp/bunya33e.html
|
|
| |
| | OriGene - Antibodies - Sphingolipid Receptor Edg1/S1P1 |
 | | EDG1, a Lysophospholipid/Lysosphingolipid Receptor, binds sphingosine-1-phosphate and may control cell proliferation, survival, and suppression of apoptosis. |  | | Homo sapiens endothelial differentiation, sphingolipid G-protein-coupled receptor, 1 (EDG1) |  | | Researchers who bought this antibody have also purchased: |
|
http://www.origene.com/antibody/TA200026.aspx
|
|
| |
| | Untitled Document |
 | | Sato M, Bielawska A, Obeid L, Hannun Y, and Trojanowska M. Modulation of Transforming Growth Factor -b (TGF -b) signaling by endogenous sphingolipid mediators. |  | | Kubo M, Czuwara-Ladykowska J, Moussa O, Markiewicz M, Smith EA, Silver RM, Jablonska S, Blaszczyk M, Watson, D, and Trojanowska M. Persistent downregulation of collagen transcription suppressor Fli1 in fibrotic scleroderma skin, Am J Path, 163:571-581, 2003 |
|
http://www.musc.edu/rheumatology/current_to_2002_publications.html
|
|
|